1,25-Dihydroxyvitamin D(3) Therapy Is Protective for Renal Function and Prevents Hyperparathyroidism in Renal Allograft Recipients

Transplantation Proceedings

Volumn 38, Issue 7, 2006, Pages 2069-2073

  Uyar, M ^a   Sezer, S ^a   Arat, Z ^a   Elsurer, R ^a   Ozdemir, F N ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCITRIOL; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; PARATHYROID HORMONE; PREDNISONE; STEROID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BONE METABOLISM; CONTROLLED STUDY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HUMAN; HYPERPARATHYROIDISM; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL PROTECTION; RETROSPECTIVE STUDY;

CALCITRIOL; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846096776     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.051     Document Type: Article

References (10)

1. Wolpaw T., Deal C.L., Fleming-Brooks S., et al. Factors influencing vertebral bone density after renal transplantation. Transplantation 58 (1994) 1186
2. Nielsen H.K., Brixen K., Kassem M., et al. Acute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals. J Bone Miner Res 6 (1991) 435
3. Boonstra A., Barrat F.J., Crain C., et al. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(-) T cells to enhance the development of Th2 cells. J Immunol 167 (2001) 4974
4. Tokuda N., Kano M., Meiri H., et al. Calcitriol therapy modulates the cellular immune responses in hemodialysis patients. Am J Nephrol 20 (2000) 129
5. Mathieu C., and Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8 (2002) 174
6. Hullett D.A., Cantorna M.T., Redaelli C., et al. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. Transplantation 66 (1998) 824
7. Bertolini D.L., Araujo P.R., Silva R.N., et al. Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model. Transplant Proc 31 (1999) 2998
8. Kreis H.A., and Ponticelli C. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation 71 (2001) SS5
9. O'Herrin J.K., Hullett D.A., Heisey D.M., et al. A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function. Am J Nephrol 22 (2002) 515
10. Gwinnera W., Suppaa S., Mengelb M., et al. Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transpl 5 (2005) 1934